Elias Sayour

Title: Innovations by Elias Sayour in Tumor Treatment

Introduction

Elias Sayour is an innovative inventor based in Gainesville, FL (US). He has made significant contributions to the field of cancer treatment, particularly in enhancing the effectiveness of immune checkpoint inhibitors. His work focuses on developing methods to sensitize tumors to these treatments, which can lead to improved outcomes for patients.

Latest Patents

Elias Sayour holds a patent titled "Methods of sensitizing tumors to treatment with immune checkpoint inhibitors." This patent outlines methods for increasing the sensitivity of tumors to immune checkpoint inhibitors (ICIs) in subjects. The methods involve administering a composition that includes a liposome containing a cationic lipid and mRNA molecules. This liposome is systemically administered to the subject. Additionally, the patent describes methods for increasing the number of activated plasmacytoid dendritic cells (pDCs) in subjects, which can enhance the immune response against tumors. The patent also discusses combination therapy with anti-PD-L1 monoclonal antibodies and related methods for preparing dendritic cell vaccines.

Career Highlights

Elias Sayour is affiliated with the University of Florida Research Foundation Inc., where he conducts his research and development work. His innovative approaches have the potential to transform cancer treatment and improve patient outcomes significantly.

Collaborations

Elias collaborates with Duane A Mitchell, who is also involved in research related to cancer therapies. Their combined expertise contributes to advancing the understanding and treatment of immune-resistant tumors.

Conclusion

Elias Sayour's work in developing methods to enhance tumor sensitivity to immune checkpoint inhibitors represents a significant advancement in cancer treatment. His innovative approaches and collaborations are paving the way for more effective therapies that could benefit many patients in the future.